1. Home
  2. LTRN vs CIF Comparison

LTRN vs CIF Comparison

Compare LTRN & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRN
  • CIF
  • Stock Information
  • Founded
  • LTRN 2013
  • CIF 1988
  • Country
  • LTRN United States
  • CIF United States
  • Employees
  • LTRN N/A
  • CIF N/A
  • Industry
  • LTRN Biotechnology: Pharmaceutical Preparations
  • CIF Trusts Except Educational Religious and Charitable
  • Sector
  • LTRN Health Care
  • CIF Finance
  • Exchange
  • LTRN Nasdaq
  • CIF Nasdaq
  • Market Cap
  • LTRN 36.0M
  • CIF 30.8M
  • IPO Year
  • LTRN 2020
  • CIF N/A
  • Fundamental
  • Price
  • LTRN $3.16
  • CIF $1.75
  • Analyst Decision
  • LTRN Strong Buy
  • CIF
  • Analyst Count
  • LTRN 1
  • CIF 0
  • Target Price
  • LTRN $25.00
  • CIF N/A
  • AVG Volume (30 Days)
  • LTRN 50.9K
  • CIF 43.9K
  • Earning Date
  • LTRN 08-07-2025
  • CIF 01-01-0001
  • Dividend Yield
  • LTRN N/A
  • CIF 10.11%
  • EPS Growth
  • LTRN N/A
  • CIF N/A
  • EPS
  • LTRN N/A
  • CIF N/A
  • Revenue
  • LTRN N/A
  • CIF N/A
  • Revenue This Year
  • LTRN N/A
  • CIF N/A
  • Revenue Next Year
  • LTRN N/A
  • CIF N/A
  • P/E Ratio
  • LTRN N/A
  • CIF N/A
  • Revenue Growth
  • LTRN N/A
  • CIF N/A
  • 52 Week Low
  • LTRN $2.55
  • CIF $1.47
  • 52 Week High
  • LTRN $6.12
  • CIF $1.77
  • Technical
  • Relative Strength Index (RSI)
  • LTRN 46.11
  • CIF 62.33
  • Support Level
  • LTRN $3.05
  • CIF $1.69
  • Resistance Level
  • LTRN $3.33
  • CIF $1.75
  • Average True Range (ATR)
  • LTRN 0.18
  • CIF 0.02
  • MACD
  • LTRN 0.01
  • CIF 0.00
  • Stochastic Oscillator
  • LTRN 26.19
  • CIF 99.67

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About CIF MFS Intermediate High Income Fund

Mfs Intermediate High Income Fund is a United States based diversified closed-end management investment company. Its investment objective is to seek high current income but may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment grade corporate bonds, government securities and other securities.

Share on Social Networks: